Pacira BioSciences (PCRX) Gross Profit (2010 - 2026)
Pacira BioSciences (PCRX) reported Gross Profit of $148.24 million for Q2 2026, up 5.7% from $140.23 million a year earlier and up 5.2% from the prior quarter.
Pacira BioSciences (PCRX) Gross Profit (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Pacira BioSciences' Gross Profit came in at $591.01 million, up 7.1% year-over-year; for FY2025, it was $576.66 million, up 8.7% from FY2024.
- Gross Profit has increased for five consecutive years, with a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
- By year, Gross Profit came in at $530.54 million in FY2024 (+8.2%), $490.31 million in FY2023 (+4.9%), $467.53 million in FY2022 (+16.5%) and $401.28 million in FY2021 (+28.5%).
- Five-year quarterly Gross Profit spans a low of $93.07 million in Q3 2021 and a high of $156.57 million in Q4 2025.
- Year over year, Gross Profit has now increased in each of the last 13 quarters, with growth averaging 7.6% over the last eight quarters.
- The high point for year-over-year Gross Profit in five years was Q1 2022 (growth of 39.1%); the low point was Q1 2023 (a decline of 8.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $140.96 million (Q1 2026), $156.57 million (Q4 2025) and $145.24 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Pacira BioSciences | 997.55 Mn | 59.58 Mn | 148.24 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 148.24 Mn |
| Mar 31, 2026 | 140.96 Mn |
| Dec 31, 2025 | 156.57 Mn |
| Sep 30, 2025 | 145.24 Mn |
| Jun 30, 2025 | 140.23 Mn |
| Mar 31, 2025 | 134.62 Mn |
| Dec 31, 2024 | 147.37 Mn |
| Sep 30, 2024 | 129.71 Mn |
| Jun 30, 2024 | 133.76 Mn |
| Mar 31, 2024 | 119.70 Mn |
| Dec 31, 2023 | 133.55 Mn |
| Sep 30, 2023 | 124.18 Mn |
| Jun 30, 2023 | 121.26 Mn |
| Mar 31, 2023 | 111.32 Mn |
| Dec 31, 2022 | 110.04 Mn |
| Sep 30, 2022 | 116.79 Mn |
| Jun 30, 2022 | 118.78 Mn |
| Mar 31, 2022 | 121.92 Mn |
| Dec 31, 2021 | 120.19 Mn |
| Sep 30, 2021 | 93.07 Mn |
Pacira BioSciences Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=PCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();